Get the Stockscreener App
210.34
2.53%
5.20
Pre-market:
217.64
7.30
+3.47%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $210.34, with a volume of 1.51M.
It is up +2.53% in the last 24 hours and up +23.80% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$205.14
Open:
$204.29
24h Volume:
1.51M
Relative Volume:
0.71
Market Cap:
$25.25B
Revenue:
$129.66B
Net Income/Loss:
$1.20B
P/E Ratio:
21.45
EPS:
9.8083
Net Cash Flow:
$375.00M
1W Performance:
+6.11%
1M Performance:
+23.80%
6M Performance:
-25.94%
1Y Performance:
-20.47%
1-Day Range:
$203.92
$210.59
1-Week Range:
$193.00
$210.59
52-Week Range:
$163.11
$315.35
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
210.34 | 25.25B | 129.66B | 1.20B | 375.00M | 9.8083 |
UNH
Unitedhealth Group Inc
|
323.48 | 293.61B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
76.58 | 98.15B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
279.92 | 73.80B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
319.36 | 70.15B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana Shareholders Approve Directors, Auditor and Incentive Plan - TipRanks
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Lobbying Update: $2,550,000 of HUMANA INC lobbying was just disclosed - Quiver Quantitative
Humana (HUM) holders approve 2026 stock plan, reject parachute proposal - Stock Titan
4 Health Care Stocks Whale Activity In Today's Session - Benzinga
CenterWell Launches Fulfillment Index to Enhance Understanding o - GuruFocus
Humana downsizes to 5,000 square feet at Biltmore office complex - The Business Journals
CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well - Business Wire
Humana, Inc. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Social Security Numbers, Medical Claims, and Patient Account Data - WFXG
Humana, Inc. Data Breach: Edelson Lechtzin LLP Launches - GlobeNewswire
Lupin Subsidiary Reaches $30 Million Settlement With Humana While Denying Allegations - PYMNTS.com
Humana Inc. (NYSE:HUM) Q4 2025 earnings call transcript - MSN
Ninety One UK Ltd Purchases 40,958 Shares of Humana Inc. $HUM - MarketBeat
Humana (HUM) Valuation Check After A Volatile Stretch In Recent Share Price Performance - Yahoo Finance
Humana Care Programs And Valuation Gap Draw Investor Attention - Yahoo Finance
Humana Inc. (NYSE:HUM) Short Interest Update - MarketBeat
Humana Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Lupin Pharmaceuticals, Inc, USA enters into settlement agreement with Humana Inc - EquityBulls
Lupin Follows Sandoz, Sun In Antitrust Suit Settlement; $30m For Humana - Citeline News & Insights
Lupin's US arm signs litigation settlement act with Humana Inc - MSN
Zacks Research Has Negative Estimate for Humana Q1 Earnings - MarketBeat
Lupin arm settles US antitrust litigation with Humana for $30 million - Business Standard
Fisher Funds Management LTD Grows Stock Holdings in Humana Inc. $HUM - MarketBeat
Lupin's US arm settles antitrust lawsuit with Humana for $30 million; details here - MSN
NewsInsurance giant Humana reveals second data breach in as many months - teiss
Lupin's US arm settles civil antitrust litigation with Humana for $30 million - Business Standard
Lupin subsidiary enters settlement agreement with Humana in US antitrust litigation - Express Pharma
Lupin settles US antitrust case with Humana for $30 million - ETLegalWorld.com
Lupin unit settles antitrust lawsuit with Humana for $30 mln By Investing.com - Investing.com Canada
Lupin's US Subsidiary Settles Antitrust Dispute with Humana for $30 Million - scanx.trade
Lupin's US arm enters into USD 30 million settlement agreement with Humana - Business Standard
Lupin’s U.S. Arm Settles Humana Antitrust Claim for $30 Million - TipRanks
Lupin unit settles antitrust lawsuit with Humana for $30 mln - Investing.com
4 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Jim Cramer Discusses Big Humana (HUM) Business - Insider Monkey
Data breach hits Humana customers in Texas, five other states - Austin American-Statesman
Humana Inc. Declares Quarterly Dividend of $0.89 (NYSE:HUM) - MarketBeat
What is Zacks Research's Estimate for Humana Q1 Earnings? - MarketBeat
Humana (NYSE:HUM) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Humana (HUM) Declares Consistent Quarterly Dividend of $0.885 - GuruFocus
Humana declares quarterly dividend of $0.885 per share - Investing.com
Humana declares quarterly dividend of $0.885 per share By Investing.com - Investing.com Canada
Humana Board Declares Payment of Quarterly Dividend to Stockholders - Business Wire
Analysts Cut Humana Price Target, Citing Competitive Pressures - National Today
How Humana’s Value-Based, Data-Driven Partnerships At Humana (HUM) Has Changed Its Investment Story - simplywall.st
Humana Price Target Cut by Analysts at Robert W. Baird - National Today
On the Line for Lung Health: Telephone Training Helps COPD Patients Perfect Inhaler Use - Business Wire
Humana (NYSE:HUM) Price Target Cut to $205.00 by Analysts at Robert W. Baird - MarketBeat
Analyst recommendations: Alphabet, Citigroup, Cloudflare, Fair Isaac, Humana… - marketscreener.com
Humana is the worst performing large-cap healthcare stock YTD - MSN
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):